Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
3
90Ṁ1112030
84%
chance
1D
1W
1M
ALL
1: The market resolves as "Yes" if the U.S. Food and Drug Administration (FDA) grants full or conditional approval for THIO-101 as a treatment for advanced Non-Small Cell Lung Cancer by the specified date.
2: The market resolves as "No" if the FDA explicitly rejects the application for THIO-101 for the mentioned indication by the specified date.
3: If neither approval nor rejection is announced by the FDA by the specified date, the market will resolve as "No."
Context: https://www.businesswire.com/news/home/20231024406334/en/
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
55% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Will an AI-designed drug get FDA approval by the end of 2025?
19% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance
Will there be an FDA approved cure for ALS (Lou Gehrig Disease) by EOY 2032?
31% chance
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
💊Will INS018_055 be FDA-approved by 2030?
48% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
30% chance